Kenvue Inc. has appointed Andrew Stanleick as president, skin health and beauty, for North America and Europe, Middle East and Africa, leading the strategic direction of the company’s portfolio of brands, including Neutrogena, Aveeno and OGX, in the regions.
Before joining Kenvue, Stanleick served as the president and CEO of BeautyHealth Company, where he led the turnaround of the company, including its flagship brand, HydraFacial. He oversaw significant revenue growth, expanded the company's global footprint and forged strategic partnerships.
Prior to that, Stanleick held the position of executive vice president at Coty Americas, leading the growth and transformation of the luxury and consumer beauty brands, including CoverGirl. He also played key roles at Unilever and L'Oréal, holding leadership positions in marketing, sales and general management.
Stainleick received his masters of philosophy from the University of Cambridge in 1996 and has been co-chair for two non-profit organizations, including the international blood cancer awareness group DKMS and Look Good Feel Better.
Charmaine England, chief growth officer, Kenvue says, “We are very pleased to have Andrew join Kenvue in this critical role. With over two decades of experience in leading the profitable growth and omni-channel transformation of global multi-brand portfolios in skin health, beauty, and fashion, Andrew brings a proven track-record of success and deep industry knowledge to strengthen the growth trajectory of our skin health and beauty segment in key markets.”
Andrew Stainleick shares, “I am thrilled to join the Kenvue team at such an exciting time for the company. As a global leader in consumer health, Kenvue’s iconic skin health and beauty brands have been trusted by consumers and recommended by healthcare professionals for generations. I look forward to helping these brands reach more consumers in new ways in 2025 and beyond.”
